| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.09▼ | 1.09▼ | 1.10▼ | 1.18▼ | 1.26▼ |
| MA10 | 1.10▼ | 1.11▼ | 1.13▼ | 1.23▼ | 1.56▼ |
| MA20 | 1.13▼ | 1.15▼ | 1.19▼ | 1.28▼ | 1.94▼ |
| MA50 | 1.21▼ | 1.23▼ | 1.23▼ | 1.66▼ | 3.25▼ |
| MA100 | 1.23▼ | 1.26▼ | 1.30▼ | 1.93▼ | 29.65▼ |
| MA200 | 1.28▼ | 1.36▼ | 1.40▼ | 2.49▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.005▼ | -0.010▼ | 0.008▲ | 0.245▲ |
| RSI | 34.647▼ | 28.124▼ | 26.385▼ | 26.602▼ | 31.835▼ |
| STOCH | 28.938 | 19.792▼ | 16.220▼ | 29.956 | 4.949▼ |
| WILL %R | -81.250▼ | -86.364▼ | -91.667▼ | -95.161▼ | -99.194▼ |
| CCI | -87.523 | -105.098▼ | -121.706▼ | -188.859▼ | -86.742 |
| ▼ GAP | $REVB Open Gap Down %2 | Set Alert |
|
Friday, October 31, 2025 05:00 PM
SAN DIEGO, CA / ACCESS Newswire / October 29, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company focused on rebalancing ...
|
|
Wednesday, September 10, 2025 05:02 AM
SAN DIEGO, CA / ACCESS Newswire / October 29, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammat ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/11/25 | 1.07 | 1.085 | 1.07 | 1.085 | 55,364 |
| 04/11/25 | 1.17 | 1.1779 | 1.07 | 1.10 | 149,894 |
| 03/11/25 | 1.24 | 1.25 | 1.17 | 1.20 | 84,389 |
| 31/10/25 | 1.24 | 1.28 | 1.23 | 1.25 | 69,310 |
| 30/10/25 | 1.26 | 1.29 | 1.25 | 1.25 | 48,794 |
| 29/10/25 | 1.34 | 1.35 | 1.28 | 1.28 | 53,964 |
| 28/10/25 | 1.28 | 1.38 | 1.23 | 1.34 | 129,907 |
| 27/10/25 | 1.29 | 1.32 | 1.26 | 1.29 | 75,167 |
| 24/10/25 | 1.21 | 1.30 | 1.193 | 1.27 | 147,700 |
| 23/10/25 | 1.16 | 1.22 | 1.15 | 1.21 | 114,070 |
|
|
||||
|
|
||||
|
|